This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Changhai Sun: Innovator in Sulfonamide Pharmaceutical Composition
Introduction
Changhai Sun is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sulfonamide compounds. His expertise and dedication to research have led to the development of a unique injectable preparation that enhances the effectiveness of sulfonamide treatments.
Latest Patents
Changhai Sun holds a patent for a sulfonamide pharmaceutical composition. This invention relates to a sulfonamide compound injectable preparation that includes a sulfonamide compound or its derivative. The preparation is created using a pharmaceutically acceptable carrier and specific preparation technologies. The resulting injectable preparation is noted for its stability, quality control, and effectiveness in medical applications. He has 1 patent to his name.
Career Highlights
Changhai Sun is associated with Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. His role in this company has allowed him to focus on the development of innovative medical technologies. His work has been instrumental in advancing pharmaceutical compositions that can improve patient outcomes.
Collaborations
Changhai Sun has collaborated with several professionals in his field, including Yi Juang Wu and Li Tian. These collaborations have fostered a productive environment for innovation and research in pharmaceutical technology.
Conclusion
Changhai Sun's contributions to the field of pharmaceuticals, particularly through his sulfonamide pharmaceutical composition, highlight his role as an innovator. His work continues to impact the medical community positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile